Chemical Compound

Epicriptine

CAS Registry Number 88660-47-3
Epicriptine chemical structure
Primary Record

Epicriptine

In stock
1,324 g
Purity
99.0 %
CAS
88660-47-3

Compound Identifiers & Properties

CAS
88660-47-3
PubChem CID
65667
SMILES
CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O
Canonical SMILES
CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12

Names & Synonyms

  • Epicriptine
  • Epicriptina
  • Epicriptinum
  • Epicryptine
  • Epicriptine [INN]
  • Epicriptinum [Latin]
  • Epicriptina [Spanish]
  • dihydro-beta-ergocryptine
  • Epicriptinum (Latin)
  • dihydro-.beta.-ergocryptine
  • beta-dihydroergocryptine
  • dihydro-beta-ergocryptin
  • RefChem:590926
  • UNII-5M64643B5U
  • 88660-47-3
  • 5M64643B5U
  • AC1L23Q5
  • Dcn 203-922
  • orb1741040
  • CHEMBL2106411
  • SCHEMBL29876500
  • CHEBI:59925
  • CHEBI:135927
  • DTXSID601024730
  • CID65667
  • ZINC4215812
  • (R)-9,10-Dihydro-?-ergocryptine
  • DCN-203-922
  • Dihydro-.beta.-ergocryptine mesilate
  • Dihydro-.beta.-ergocryptine mesylate
  • EBC-27343
  • 9,10alpha-Dihydro-13'-epi-beta-ergocryptine
  • C32-H43-N5-O5
  • DB11275
  • Dihydroergocristine Mesilate EP Impurity I
  • NS00069851
  • (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-[(2R)-butan-2-yl]-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • EN300-24137087
  • 9,10-.ALPHA.-DIHYDRO-13'-EPI-.BETA.-ERGOCRYPTINE
  • 9,10-ALPHA-DIHYDRO-13'-EPI-BETA-ERGOCRYPTINE
  • Q27262549
  • 9,10-dihydro-12'-hydroxy-2'-isopropyl-5'-(1-methylpropyl)ergotaman-3',6',18-trione
  • ERGOTAMAN-3',6',18-TRIONE, 9,10-DIHYDRO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(1-METHYLPROPYL)-, (5'.ALPHA.(R),10.ALPHA.)-
  • (10alphaH)-5'alpha-(butan-2-yl)-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman
  • (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-[(2R)-butan-2-yl]-2-hydroxy-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide
  • (6aR,9R,10aR)-N-((1S,2S,4R,7S)-7-((2R)-butan-2-yl)-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
  • (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-((R)-sec-butyl)-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
  • ERGOTAMAN-3',6',18-TRIONE, 9,10-DIHYDRO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(1-METHYLPROPYL)-, (5'ALPHA(R),10ALPHA)-